Literature DB >> 25277453

Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.

Scott A Small1.   

Abstract

Some of the most common and devastating disorders of the brain target the hippocampal formation. The hippocampal formation is a complex circuit of interconnected regions, and it is assumed that clues into the causes of these disorders are embedded within the circuit. Neuroimaging tools have been optimized to interrogate the malfunctioning hippocampal circuit, and by applying these tools to patients in the earliest stages of disease and to animal models, patterns of regional vulnerability have been established for Alzheimer's disease, schizophrenia, and cognitive aging. More recently, studies have begun deciphering the cellular and molecular reasons underlying regional dysfunction. Collectively, this information clarifies the pathophysiology of these disorders and informs on therapeutic strategies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25277453      PMCID: PMC4185396          DOI: 10.1016/j.neuron.2014.08.030

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  82 in total

1.  Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging.

Authors:  Laura E M Wisse; Geert Jan Biessels; Sophie M Heringa; Hugo J Kuijf; Dineke H L Koek; Peter R Luijten; Mirjam I Geerlings
Journal:  Neurobiol Aging       Date:  2014-03-03       Impact factor: 4.673

2.  Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing.

Authors:  Anja W Fjorback; Matthew Seaman; Camilla Gustafsen; Arnela Mehmedbasic; Suzanne Gokool; Chengbiao Wu; Daniel Militz; Vanessa Schmidt; Peder Madsen; Jens R Nyengaard; Thomas E Willnow; Erik Ilsø Christensen; William B Mobley; Anders Nykjær; Olav M Andersen
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

3.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

Authors:  Shiming Ye; Yadong Huang; Karin Müllendorff; Liming Dong; Gretchen Giedt; Elaine C Meng; Fred E Cohen; Irwin D Kuntz; Karl H Weisgraber; Robert W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

5.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

7.  Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.

Authors:  Kunie Ando; Jean-Pierre Brion; Virginie Stygelbout; Valérie Suain; Michèle Authelet; Robert Dedecker; Anaïs Chanut; Pascale Lacor; Jérémie Lavaur; Véronique Sazdovitch; Ekaterina Rogaeva; Marie-Claude Potier; Charles Duyckaerts
Journal:  Acta Neuropathol       Date:  2013-04-16       Impact factor: 17.088

8.  Pharmacological chaperones stabilize retromer to limit APP processing.

Authors:  Vincent J Mecozzi; Diego E Berman; Sabrina Simoes; Chris Vetanovetz; Mehraj R Awal; Vivek M Patel; Remy T Schneider; Gregory A Petsko; Dagmar Ringe; Scott A Small
Journal:  Nat Chem Biol       Date:  2014-04-20       Impact factor: 15.040

9.  Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48.

Authors:  Elias Pavlopoulos; Sidonie Jones; Stylianos Kosmidis; Maggie Close; Carla Kim; Olga Kovalerchik; Scott A Small; Eric R Kandel
Journal:  Sci Transl Med       Date:  2013-08-28       Impact factor: 17.956

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  19 in total

1.  Circuitry-Based Human Neuroanatomy for the Next Generation in Psychiatry and Neuroscience.

Authors:  Takeshi Sakurai
Journal:  Mol Neuropsychiatry       Date:  2017-09-07

2.  Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study.

Authors:  Ragy R Girgis; Mark Slifstein; Gary Brucato; Lawrence S Kegeles; Tiziano Colibazzi; Jeffrey A Lieberman; Anissa Abi-Dargham
Journal:  Mol Psychiatry       Date:  2020-11-05       Impact factor: 13.437

3.  Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA1.

Authors:  Vincent Planche; Ismail Koubiyr; José E Romero; José V Manjon; Pierrick Coupé; Mathilde Deloire; Vincent Dousset; Bruno Brochet; Aurélie Ruet; Thomas Tourdias
Journal:  Hum Brain Mapp       Date:  2018-01-13       Impact factor: 5.038

Review 4.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

5.  Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.

Authors:  Sharon S Lander; Usman Khan; Nicole Lewandowski; Darpan Chakraborty; Frank A Provenzano; Susana Mingote; Sergiy Chornyy; Francesca Frigerio; Pierre Maechler; Hanoch Kaphzan; Scott A Small; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

6.  Young Adults with a Parent with Dementia Show Early Abnormalities in Brain Activity and Brain Volume in the Hippocampus: A Matched Case-Control Study.

Authors:  Ian M McDonough; Christopher Mayhugh; Mary Katherine Moore; Mikenzi B Brasfield; Sarah K Letang; Christopher R Madan; Rebecca S Allen
Journal:  Brain Sci       Date:  2022-04-13

Review 7.  Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.

Authors:  Syed Faraz Kazim; Khalid Iqbal
Journal:  Mol Neurodegener       Date:  2016-07-11       Impact factor: 14.195

8.  Cortical amyloid burden and age moderate hippocampal activity in cognitively-normal adults.

Authors:  Zhuang Song; Ian M McDonough; Peiying Liu; Hanzhang Lu; Denise C Park
Journal:  Neuroimage Clin       Date:  2016-05-26       Impact factor: 4.881

9.  Barriers to developing a valid rodent model of Alzheimer's disease: from behavioral analysis to etiological mechanisms.

Authors:  Darryl C Gidyk; Scott H Deibel; Nancy S Hong; Robert J McDonald
Journal:  Front Neurosci       Date:  2015-07-29       Impact factor: 4.677

10.  DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice.

Authors:  Elsa Suberbielle; Biljana Djukic; Mark Evans; Daniel H Kim; Praveen Taneja; Xin Wang; Mariel Finucane; Joseph Knox; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Lennart Mucke
Journal:  Nat Commun       Date:  2015-11-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.